The Latest Breaking News from Moderna

Moderna said Wednesday it wouldn’t raise the price of its COVID-19 vaccine after a public outcry.

The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.

A Relative Strength Rating upgrade for Moderna shows improving technical performance. Will it continue?

After railing at the injustices of U.S. health care for decades, Sen. Bernie Sanders in January became the new chairman of the Senate Health, Education, Labor & Pensions Committee. The job gives the health care industry’s biggest Washington nemesis an unprecedented opportunity to shape health care reform in Congress. But…

Australians aged 18 and over will be eligible for a COVID booster from February 20 if they have not had a vaccine dose or infection in the past six months.

“Patients need to advocate for themselves."

WASHINGTON — The Biden administration’s plan to unwind the public health emergency tied to the COVID-19 pandemic will spur a whirlwind of changes related to telehealth, Medicaid, pharmaceuticals and other priorities.

The public health emergency created an array of health flexibilities, impacting everything from Medicaid to telehealth coverage.

The health department is expected to make a decision on the fifth dose within weeks. Here's what we know so far.

Dr Ivarsson recalled the emotional day when the results from Moderna’s vaccine trials were announced.

The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.